Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study.

ABSTRACT:

Objective

To describe trends in the rate and daily dose of opioids used among commercial and Medicare Advantage beneficiaries from 2007 to 2016.

Design

Retrospective cohort study of administrative claims data.

Setting

National database of medical and pharmacy claims for commercially insured and Medicare Advantage beneficiaries in the United States.

Participants

48 million individuals with any period of insurance coverage between 1 January 2007 and 31 December 2016, including commercial beneficiaries, Medicare Advantage beneficiaries aged 65 years and over, and Medicare Advantage beneficiaries under age 65 years (eligible owing to permanent disability).

Main endpoints

Proportion of beneficiaries with any opioid prescription per quarter, average daily dose

SUBMITTER: Jeffery MM 

PROVIDER: S-EPMC6066997 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature